News & Press

PRESS

/

Forbes

/

7.22.0206

Forbes highlights Strive Pharmacy’s investments in infrastructure, quality, and regulatory readiness for the future of peptide compounding.

Forbes highlights Strive Pharmacy’s investments in infrastructure, quality, and regulatory readiness for the future of peptide compounding.

PRESS

/

Reuters

/

6.17.2026

Reuters Cites Strive Pharmacy’s Valerie Richards in Progesterone Supply Report

Reuters Cites Strive Pharmacy’s Valerie Richards in Progesterone Supply Report

PRESS

/

In Touch Weekly

/

4.22.2026

In Touch Weekly spotlights how Strive Pharmacy is advancing personalized medicine through quality, clinical oversight, and patient-centered care.

In Touch Weekly spotlights how Strive Pharmacy is advancing personalized medicine through quality, clinical oversight, and patient-centered care.

PRESS

/

Kiplinger

/

5.26.2026

Kiplinger Features Strive Pharmacy CEO Nate Hill on Healthcare and Retirement Planning

Kiplinger Features Strive Pharmacy CEO Nate Hill on Healthcare and Retirement Planning

PRESS

/

Grit Daily

/

3.26.2025

Redefining Personalized Medicine: How Nate Hill and Strive Pharmacy Are Transforming Compounded Healthcare

Redefining Personalized Medicine: How Nate Hill and Strive Pharmacy Are Transforming Compounded Healthcare

PRESS

/

/

12.24.2024

FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions

FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions

PRESS

/

/

12.20.2024

Strive offers ‘right place, right time medications’

Strive offers ‘right place, right time medications’

PRESS

/

/

12.19.2024

IBD 50's Hims Tumbles On Bad News For Weight-Loss Drug

IBD 50's Hims Tumbles On Bad News For Weight-Loss Drug

PRESS

/

/

12.5.2024

How This Age-Old Battle That Could Further Rattle Eli Lilly Stock

How This Age-Old Battle That Could Further Rattle Eli Lilly Stock

PRESS

/

/

11.4.2024

IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory

IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory

PRESS

/

/

11.4.2024

IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory

IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory

PRESS

/

/

11.4.2024

IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory

IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory

PRESS

/

/

10.27.2024

Why compounders and telehealth providers are undeterred by the potential end of the weight-loss drug shortage

Why compounders and telehealth providers are undeterred by the potential end of the weight-loss drug shortage

PRESS

/

/

10.30.2024

Strive Compounding Pharmacy Acquires 50,000 sq. ft. Facility in St. Louis for Turnkey Telehealth Compounding and Fulfillment

Strive Compounding Pharmacy Acquires 50,000 sq. ft. Facility in St. Louis for Turnkey Telehealth Compounding and Fulfillment

PRESS

/

/

10.29.2024

#HLTH24: GLP-1 compounding pharmacies took center stage at digital health’s biggest conference

#HLTH24: GLP-1 compounding pharmacies took center stage at digital health’s biggest conference

PRESS

/

Yahoo

/

10.7.2024

Why compounders and telehealth providers are undeterred by the potential end of the weight-loss drug shortage

Why compounders and telehealth providers are undeterred by the potential end of the weight-loss drug shortage

Need brand assets? Download our brand guidelines here.

DOWNLOAD BRAND KIT

CART

Product Title
$0
$0
Option 1 / Option 2 / Option 3
Subscription Plan Info
Product Discount (-$0)
COUPON1 (-$0)
-
+

REMOVE

Your cart’s empty…  
Add something awesome!
Cart note
Subtotal:
$0
COUPON2
-$0
Order Discount:
-$0
Cart Total:
$0
CONTINUE SHOPPING